CVS Health Corporation (NYSE:CVS) Shares Sold by Plimoth Trust Co. LLC

Plimoth Trust Co. LLC cut its position in CVS Health Corporation (NYSE:CVS) by 83.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,060 shares of the pharmacy operator’s stock after selling 24,901 shares during the period. Plimoth Trust Co. LLC’s holdings in CVS Health were worth $343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the company. Hopwood Financial Services Inc. purchased a new stake in shares of CVS Health in the fourth quarter valued at approximately $29,000. McIlrath & Eck LLC grew its holdings in CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 174 shares in the last quarter. Financial Perspectives Inc raised its holdings in shares of CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator’s stock worth $36,000 after acquiring an additional 466 shares during the period. Compass Planning Associates Inc purchased a new stake in shares of CVS Health in the fourth quarter valued at about $37,000. Finally, Providence First Trust Co acquired a new stake in CVS Health during the fourth quarter worth about $42,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on CVS. Morgan Stanley reaffirmed an “overweight” rating on shares of CVS Health in a research report on Tuesday, April 15th. Piper Sandler lifted their target price on CVS Health from $72.00 to $74.00 and gave the company an “overweight” rating in a research report on Friday, March 21st. Wall Street Zen upgraded CVS Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Barclays set a $79.00 price objective on shares of CVS Health and gave the company an “overweight” rating in a report on Monday, June 2nd. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and set a $84.00 target price (up previously from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Two analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average price target of $74.75.

Insider Activity

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of the company’s stock in a transaction dated Thursday, June 5th. The shares were acquired at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the acquisition, the director now owns 12,007 shares in the company, valued at $764,845.90. The trade was a 15.04% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 1.22% of the company’s stock.

CVS Health Stock Down 0.3%

CVS Health stock opened at $66.91 on Friday. The firm has a market capitalization of $84.64 billion, a P/E ratio of 15.97, a P/E/G ratio of 0.96 and a beta of 0.56. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51. The stock’s fifty day simple moving average is $64.98 and its 200-day simple moving average is $60.35.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter in the prior year, the business earned $1.31 EPS. CVS Health’s revenue was up 7.0% on a year-over-year basis. As a group, equities analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.